Midgard Science

Philogen

Sovicille, Italy philogen.com

From their website, Nov 2026

Work here? Claim this listing

About

Philogen is a Swiss-Italian biotechnology company founded in 1996 that discovers, manufactures, and develops targeted drugs for cancer and other serious conditions. It operates from sites in Italy and Switzerland and runs work from discovery through clinical development.

Services

  • Target discovery

    Identifies accessible disease targets and discovers antibodies and small organic ligands.

    Assays & in vitro testing

  • Ligand screening through discovery collaborations

    Offers flexible collaboration structures for screening binders against one or multiple targets using proprietary discovery platforms.

    Assays & in vitro testing

  • DNA-encoded library discovery

    Uses DNA-encoded chemical libraries for fast and cost-effective drug discovery.

    Assays & in vitro testing

  • Antibody discovery

    Uses antibody phage libraries to isolate fully human monoclonal antibodies against antigens of interest.

    Assays & in vitro testing

  • Cyclic peptide discovery

    Uses proprietary phage libraries of short cyclic peptides for screening and binder isolation.

    Assays & in vitro testing

  • Prototype development

    Couples targeting ligands with bioactive payloads to generate targeted drug candidates.

    Assays & in vitro testing

  • Preclinical evaluation

    Tests targeted drugs in preclinical models.

    ADME, DMPK & toxicology

  • Cell line development

    Provides customized activities for cell line development in collaboration settings.

    Cell line development

  • GMP manufacturing

    Manufactures investigational medicinal products and commercial products in its GMP facilities near Siena.

    CDMO: development & manufacturing

  • Manufacturing collaborations

    Offers manufacturing collaborations for selected industrial and academic partners.

    CDMO: development & manufacturing

  • Clinical trial management

    Runs and manages clinical trials in-house from Phase I through Phase III.

  • Bioanalytics

    Lists bioanalytics as one of its service areas.

    Assays & in vitro testing

  • Preclinical development

    Couples targeting ligands with bioactive payloads and tests the resulting targeted drugs in preclinical models.

  • Clinical development

    Runs and manages clinical trials in-house from Phase I through Phase III.

  • Discovery collaborations

    Offers flexible collaboration structures for screening binders against selected targets.

  • DNA-encoded library screening

    Uses proprietary DNA-encoded chemical libraries for drug discovery screening.

  • R&D discovery

    Runs discovery collaborations through Philochem for screening binders against selected targets using proprietary libraries and platforms.

  • Clinical trials

    Runs and manages clinical trials in-house across Phase I through Phase III.

Capabilities

Processes
Small molecule · Antibody · Peptide · Cell therapy · Recombinant protein · Antibodies · Peptides · Bioanalysis · Small molecules
Capacity
More than one billion compounds · More than 100 billion members · Two GMP manufacturing facilities near Siena · Up to Phase III clinical trials · 21 clinical trials · More than one billion compounds in DNA-encoded chemical libraries · More than 100 billion members in antibody phage libraries · More than 100 billion members in short cyclic peptide phage libraries

Equipment

  • DNA-encoded chemical libraries
  • Antibody phage libraries

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

  • GLPSelf-reported

  • ISO 9001:2015Self-reported

Industries served

  • Biotech
  • Pharmaceuticals
  • Oncology

Company

Type
CRDMO
Founded
1996

Locations

Based in
Sovicille, Italy
Sites
Siena, Italy · Monteriggioni (SI), Italy · Milano, Italy · Otelfingen, Switzerland · Sovicille, Italy · Monteriggioni, Italy · Zürich, Switzerland

Contacts

Similar labs

Work here? Claim this listing